Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy

QR Code

Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy

© 2018 Royal Pharmaceutical Society Objectives: Pigment epithelium-derived factor (PEDF), a multifunctional endogenous glycoprotein, has a very wide range of biological actions, notably in bone homeostasis. The question has been raised regarding the place of PEDF in the treatment of bone disorders a...

Full description

Bibliographic Details
Main Authors:	Baxter-Holland, M., Dass, Crispin
Format:	Journal Article
Published:	John Wiley & Sons Ltd. 2018
Online Access:	http://hdl.handle.net/20.500.11937/73327

Similar Items

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical
by: Lee, P., et al.
Published: (2016)

Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: Evidence in silico, in vitro and in vivo
by: Lee, P., et al.
Published: (2016)

Pigment Epithelium-Derived Factor: Chemistry, Structure, Biology, and Applications
by: Becerra, S.P., et al.
Published: (2012)

Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation
by: Filiz, G., et al.
Published: (2012)

Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)

Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls
by: Poon, B., et al.
Published: (2016)

Pigment Epithelium-Derived Factor as an Impending Therapeutic Agent Against Vascular Epithelial Growth Factor-Driven Tumor-Angiogenesis
by: Manalo, K., et al.
Published: (2011)

Insulin antagonises pigment epithelium-derived factor (PEDF)-induced modulation of lineage commitment of myocytes and heterotrophic ossification
by: Carnagarin, R., et al.
Published: (2018)

Pigment epithelium-derived factor as a natural matrix metalloproteinase inhibitor: a comparison with classical matrix metalloproteinase inhibitors used for cancer treatment
by: Alcantara, M., et al.
Published: (2014)

Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective
by: Manalo, K., et al.
Published: (2011)

Bone drug targets
by: Dass, Crispin
Published: (2018)

Pigment epithelium-derived factor and menopause in metastatic breast cancer
by: Brook, Naomi Louise
Published: (2022)

Transdifferentiation of myoblasts into osteoblasts - possible use for bone therapy
by: Lin, Daphne, et al.
Published: (2017)

Pigment Epithelium-derived Factor and Insulin Crosstalk in Skeletal Muscle Biology
by: Carnagarin, Revathy
Published: (2017)

The Role of Pigment Epithelium-derived Factor in Breast Cancer Cell Metabolism
by: Abooshahab, Raziyeh
Published: (2025)

Current research on pharmacologic and regenerative therapies for osteoarthritis
by: Zhang, W., et al.
Published: (2016)

Modulatory and regenerative potential of transplanted bone marrow derived mesenchymal stem cells on rifampicin-induced kidney toxicity
by: Danjuma, Lawal, et al.
Published: (2018)

Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)

The potential role of free chitosan in bone trauma and bone cancer management
by: Tan, M., et al.
Published: (2014)

Translation of remote control regenerative technologies for bone repair
by: Markides, Hareklea, et al.
Published: (2018)

The osteocyte: master directors of bone remodelling, mineralisation and phosphate-calcium homeostasis
by: Khalid, Kamarul Ariffin, et al.
Published: (2019)

Pigment epithelium-derived factor stimulates skeletal muscle glycolytic activity through NADPH oxidase-dependent reactive oxygen species production
by: Carnagarin, R., et al.
Published: (2016)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)

The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010)

Treatment of bone disorders with parathyroid hormone: Success and pitfalls
by: Ng, P., et al.
Published: (2016)

Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)

PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)

Extract of palm leaf and a composition comprising the same for increasing bone mineral density and arterial homeostasis
by: Mohamed, Suhaila, et al.
Published: (2011)

Breast cancer bone metastases: pathogenesis and therapeutic targets
by: Brook, Naomi, et al.
Published: (2018)

Fish Bone Waste As Potential Source Of Apatite For Bone Replacement
by: Ivon, Tiew
Published: (2018)

Molecular aspects of glucose homeostasis in skeletal muscle - A focus on the molecular mechanisms of insulin resistance.
by: Carnagarin, R., et al.
Published: (2015)

Pigment epithelium-derived factor (PEDF) regulates metabolism and insulin secretion from a clonal rat pancreatic beta cell line BRIN-BD11 and mouse islets
by: Chen, Y., et al.
Published: (2016)

Nanoparticle-Mediated Interleukin-12 Cancer Gene Therapy
by: Hallaj-Nezhadi, S., et al.
Published: (2010)

Bone grafting and bone graft substitutes
by: Kaveh, Kamran, et al.
Published: (2010)

Folate-mediated macromolecule delivery across the epithelium
by: Moradi, Emilia
Published: (2012)

Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
by: Mansur, Sity Aishah
Published: (2015)

Pre-mineralisation effect of nanobiocomposite bone scaffold towards bone marrow-derived stem cells growth and differentiation
by: Chow, Yoke Yue, et al.
Published: (2019)

Systemic leptin administration alters callus VEGF levels and enhances bone fracture healing in wildtype and ob/ob mice
by: Wu, Z., et al.
Published: (2018)

Bone marrow seeded bone graft versus bone graft; compact bone critical sized defect healing pattern in rabbit
by: Kaveh, Kamran, et al.
Published: (2010)

Tricalcium phosphate/hydroxyapatite (TCP-HA) bone scaffold as potential candidate for the formation of tissue engineered bone
by: Sulaiman, Shamsul, et al.
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m1rbkhvppgngfb1akusi8bd5h2